Advanced Search
WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205
Citation: WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205

Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors

More Information
  • A series of hydrogen sulfide-releasing derivatives of open ring 3-n-butylphthalide( 5a - 5f )were designed, synthesized, and their structures were confirmed by MS and 1H NMR. The inhibitory activity of the target compounds against adenosine diphosphate(ADP)and arachidonic acid(AA)-induced platelet aggregation was evaluated in vitro by Born′s turbidimetric assay. In comparison with 3-n-butylphthalide(NBP), compound 5e possessed better antiplatelet aggregation activity. Therefore, it may be utilized as a lead compound for further investigation.
  • [1]
    Wang XL, Wang LN, Li TT, et al. Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents[J].J Med Chem,2013,56(7):3078-3089.
    [2]
    Wang XL,Wang LN,Xiao S,et al.Design,synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents[J].Org Biomol Chem,2014,12(31):5995-6004.
    [3]
    Zhang Y,Wang L,Zhang LY,et al.Effects of 1-(1-hydroxypentyl)-benzoate on platelet aggregation and thrombus formation in rats[J].Drug Dev Res,2004,63(11):174-180.
    [4]
    Wang XL,Li Y,Zhao Q,et al.Design,synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as anti-platelet and antithrombotic agents[J].Org Biomol Chem,2011,9(16):5670-5681.
    [5]
    Wang XL,Zhao Q,Wang XL, et al.Studies on the enantiomers of ZJM-289:synthesis and biological evaluation of antiplatelet,antithrombotic and neuroprotective activities[J].Org Biomol Chem,2012,10(45):9030-9040.
    [6]
    Zhang Y, Tang ZH, Ren Z, et al. Hydrogen sulfide,the next potent preventive and therapeutic agent in aging and age-associated diseases[J].Mol Cell Biol,2013,33(6):1104-1113.
    [7]
    Luo Y,Liu X,Zheng Q,et al.Hydrogen sulfide prevents hypoxia-induced apoptosis via inhibition of an H2O2-activated calcium signaling pathway in mouse hippocampal neurons[J].Biochem Biophys Res Commun,2012,425(2):473-477.
    [8]
    Kimura K,Kimura H.Hydrogen sulfide protects neurons from oxidative stress[J].FASEB J,2004,18(10):1165-1172.
    [9]
    Caliendo G,Cirino G,Santagada V,et al.Synthesis and biological effects of hydrogen sulfide(H2S):development of H2S-releasing drugs as pharmaceuticals[J].J Med Chem,2010,53(17):6275-6286.
    [10]
    Li Q,Lv J,Yang MQ,et al.Effects of NBP combined with Xueshuantong on the improvement of neural function in patients with ischemic cerebral stroke[J].Chin J Biochem Pharm(中国生化药物杂志),2014,6(34):107-109.
    [11]
    Ma HZ, Wu B, Liu SX, et al. The efficacy of the therapy of butylphathalide combined with fasudil for acute cerebral infarction and its influence on hs-CRR[J].Prog Mod Biomed(现代生物医学进展),2014,13(13):2543-2546.
    [12]
    Xu JY.Clinical observation of butylphthalide combined with aspirin in treatment of acute watershed cerebral infarction[J].Drugs Clini(现代药物与临床),2015,30(5):535-538.
    [13]
    Lazzarato L, Chegaev K, Marini E, et al. New nitric oxide or hydrogen sulfide releasing aspirins[J].J Med Chem,2011,54(15):5478-5484.
    [14]
    Wang XL, Wang LN, Huang ZJ, et al. Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents[J].Bioorg Med Chem Lett,2013,23(7):1985-1988.
  • Related Articles

    [1]WANG Ziyuan, TAO Hui, XIAO Yingxue, YIN Zhiqi. Network pharmacology-based study of the mechanism of Ginkgo biloba extract (GBE) in the treatment of atherosclerosis by activating PPARγ[J]. Journal of China Pharmaceutical University, 2025, 56(2): 225-235. DOI: 10.11665/j.issn.1000-5048.2024032301
    [2]DONG Xiaoqiang, WEN Chang, XU Jindan, SHI Lexue, HU Yulong, LI Jieming, DONG Chunhong, DING Kan. Research progress on active mechanism and structure feature of polysaccharides from Zizyphus jujube in Rhamnaceae plants[J]. Journal of China Pharmaceutical University, 2024, 55(4): 443-453. DOI: 10.11665/j.issn.1000-5048.2024051301
    [3]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [4]MA Rui, TIAN Jinhua, JIANG Jun, JIN Xin. Inhibitory activities of ginsenosides on the activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2016, 47(5): 614-618. DOI: 10.11665/j.issn.1000-5048.20160519
    [5]ZHU Kuiniu, WU Zhengfeng, JIANG Cuihua, CAO Lanjie, ZHANG Jian, YIN Zhiqi. Advances on hypoglycemic activity and mechanism of triterpenoids[J]. Journal of China Pharmaceutical University, 2015, 46(6): 764-770. DOI: 10.11665/j.issn.1000-5048.20150622
    [6]SHEN Kai, KOU Junping, YU Boyang. Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(5): 532-540. DOI: 10.11665/j.issn.1000-5048.20150503
    [7]WU Keqin. Antitumor activity and mechanism of saikosaponin D combined with oxaliplatin on A549 cells-bearing nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(3): 355-358. DOI: 10.11665/j.issn.1000-5048.20150316
    [8]ZHANG Qian, CHEN Cen, YANG Fengqing, XIA Zhining. Mechanism of agonist-induced platelet activation and research progress of anti-platelet drugs[J]. Journal of China Pharmaceutical University, 2014, 45(6): 632-648. DOI: 10.11665/j.issn.1000-5048.20140604
    [9]SONG Huayuan, ZHOU Danli, HAN Yuan, LIU Wentao. Baicalin attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2014, 45(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20140317
    [10]CHENG Yu-si, DAI De-zai, JI Hui, DAI Yin. Mechanism of endothelin receptor antagonist CPU0213 and calcium antagonist CPU86017 ameliorated rats′ heart failure induced by isoproterenol[J]. Journal of China Pharmaceutical University, 2011, 42(1): 58-63.
  • Cited by

    Periodical cited type(4)

    1. 谢金平,黄淼,朱梦雅,陈怡,邵蓉. 监管科学视角下增材制造(3D打印)药物研发上市关键问题及监管政策研究. 中国食品药品监管. 2025(02): 50-61 .
    2. 王美晴,段小群. 3D打印技术在药物制剂领域的研究进展. 广东化工. 2024(02): 67-68+62 .
    3. 张隽齐,杨柳榴,陈芳. 3D打印技术在膜剂制备中的研究进展. 中国医药工业杂志. 2024(03): 326-334 .
    4. 谭志柱,梁兆铭,邓永健. 3D打印技术在汽车轮胎模具领域的应用案例分析. 机电工程技术. 2024(12): 131-134 .

    Other cited types(4)

Catalog

    Article views PDF downloads Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return